Odyssey Therapeutics, Inc.
ODTXNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $531.97M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $15.10$29.05
- Volume (live)
- -
- Avg. volume (3M)
- 363.00K
Odyssey Therapeutics (ODTX) Stock Price & Financial Analysis
Odyssey Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $16.90 - $17.50 |
|---|---|
| 52-Week High | $29.05 |
| 52-Week Low | $15.10 |
| Open | $17.45 |
| Volume (last close) | 219.37K |
| Average Volume (3M) | 363.00K |
| Revenue (TTM) | 2.88M |
|---|---|
| Net Income (TTM) | -170.72M |
| Free Cash Flow (TTM) | -149.72M |
| EPS (TTM) | −$10.59 |
| Profit Margin | -5933.96% |
| Operating Margin | -5845.12% |
| Return on Equity (ROE) | -40.53% |
| Debt to Equity | 0.06 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 531.97M |
|---|---|
| Shares Outstanding | 30.28M |
| Price to Sales (P/S) | 184.90 |
| Price to Book (P/B) | 1.26 |
| EV/EBITDA | -2.81 |
| 50-Day MA | $22.47 |
|---|
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Odyssey Therapeutics at a Glance
As of the Oct 16, 2026 close, Odyssey Therapeutics (ODTX) has a market capitalization of $531.97M. The stock trades at 184.9× sales. Over the trailing twelve months it lost $170.72M on revenue of $2.88M and burned $149.72M of free cash flow. Revenue fell 33.5% year over year.
As of its latest reported balance sheet, it holds $82.03M in cash and securities against $24.82M of debt, a net cash position of $57.21M.
Odyssey Therapeutics does not currently pay a dividend.
At $17.17 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $15.10 to $29.05.
Based on 4 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $34.33, 99.9% above the Oct 16, 2026 close.
Frequently Asked Questions About Odyssey Therapeutics
What is the current stock price for ODTX?
As of the Oct 16, 2026 close, ODTX stock trades at $17.17. The 52-week range is $15.10–$29.05, with a day range of $16.90–$17.50.
What is the P/E ratio for ODTX?
The P/E ratio (Price-to-Earnings) for ODTX is shown in the Key Statistics section. This valuation metric helps compare Odyssey Therapeutics, Inc. to industry peers.
Does ODTX pay dividends?
Odyssey Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ODTX?
Based on ratings from 4 professional analysts over the last 90 days, the consensus for ODTX is Buy. The average 12-month price target is $34.33, a 99.9% upside from the Oct 16, 2026 close of $17.17.
What is the market cap of ODTX?
As of the Oct 16, 2026 close, Odyssey Therapeutics's market capitalization is $519.9M, classifying it as a small-cap company. Odyssey Therapeutics operates in the Healthcare sector within the Biotechnology industry.